Author Correction: Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features.

Saved in:
Bibliographic Details
Title: Author Correction: Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features.
Authors: Mendelaar PAJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., van Riet J; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Cancer Computational Biology Center, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Angus L; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Labots M; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands., Steeghs N; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Hendriks MP; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Department of Medical Oncology, Northwest Clinics, Alkmaar, The Netherlands., Cirkel GA; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Department of Medical Oncology, Meander Medical Center, Amersfoort, The Netherlands., van Rooijen JM; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Department of Medical Oncology, Martini Hospital, Groningen, The Netherlands., Ten Tije AJ; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Department of Medical Oncology, Amphia Hospital, Breda, The Netherlands., Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands., Cuppen E; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, The Netherlands.; Hartwig Medical Foundation, Amsterdam, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands., Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands. s.wilting@erasmusmc.nl.
Source: Nature communications [Nat Commun] 2021 May 26; Vol. 12 (1), pp. 3269. Date of Electronic Publication: 2021 May 26.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2041-1723
DOI:10.1038/s41467-021-23629-4